Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

• Váldodahkkit: Valentina Cossiga (Dahkki), Marco Sanduzzi-Zamparelli (Dahkki), Victor Sapena (Dahkki), Maria Guarino (Dahkki), Marcello Dallio (Dahkki), Emanuele Torrisi (Dahkki), Luca Pignata (Dahkki), Alessandro Federico (Dahkki), Federico Salomone (Dahkki), Filomena Morisco (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction and Aims: HCV eradication by direct-acting antivirals (DAAs) improves liver outcomes and reduces overall liver mortality. However, patients with advanced chronic liver disease (ACLD) may experience a progression of liver disease despite viral clearance. Silybin has shown hepatoprotectiv...